TANDEM

WIPO WIPO 2012

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark TANDEM was filed as Word mark on 12/07/2012 at the World Intellectual Property Organization.

Trademark Details Last update: February 24, 2023

Trademark form Word mark
File reference 1156119
Countries Australia Switzerland China Colombia Cuba em Japan
Application date December 7, 2012
Expiration date August 24, 2015

Trademark owner

Clarendon House,
2 Church Street,
GB

Trademark representatives

1055 Thomas Jefferson St. NW, Suite 400 Washington DC 20007 US

goods and services

10 Medical devices; medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; drug delivery device, namely a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; drug delivery device, namely a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment

Trademark history

Date Document number Area Entry
February 26, 2016 2016/19 Gaz US RAW: Total Ceasing Effect
April 16, 2015 2015/25 Gaz CO RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 27, 2014 2014/48 Gaz JP Rejection
April 15, 2014 2014/20 Gaz CH Rejection
March 17, 2014 2014/12 Gaz CU Rejection
March 3, 2014 2014/19 Gaz RAW: Limitation
February 27, 2014 2014/9 Gaz EM Rejection
January 30, 2014 2014/5 Gaz JP Rejection
January 7, 2014 2014/5 Gaz CN Rejection
October 29, 2013 2013/44 Gaz CO Rejection
May 28, 2013 2013/24 Gaz US Correction
May 6, 2013 2013/19 Gaz AU Rejection
December 7, 2012 2013/15 Gaz US Registration

ID: 141156119